Portal de Periódicos da CAPES

Glucocorticosteroids and rhinitis

1993; Wiley; Volume: 48; Issue: 7 Linguagem: Inglês

10.1111/j.1398-9995.1993.tb01103.x

1398-9995

Niels Mygind,

Olfactory and Sensory Function Studies

AllergyVolume 48, Issue 7 p. 476-490 Free Access Glucocorticosteroids and rhinitis N. Mygind, Corresponding Author N. Mygind Otopathological Laboratory, Department of Otorhinolaryngology, and Allergy Clinic, Department of Internal Medicine, Rigshospitalet, Copenhagen, DenmarkDr Niels Mygind, Otopathological Laboratory, Department of Otolaryngology, Rigshospitalet, DK-2100 Copenhagen, DenmarkSearch for more papers by this author N. Mygind, Corresponding Author N. Mygind Otopathological Laboratory, Department of Otorhinolaryngology, and Allergy Clinic, Department of Internal Medicine, Rigshospitalet, Copenhagen, DenmarkDr Niels Mygind, Otopathological Laboratory, Department of Otolaryngology, Rigshospitalet, DK-2100 Copenhagen, DenmarkSearch for more papers by this author First published: October 1993 https://doi.org/10.1111/j.1398-9995.1993.tb01103.xCitations: 65AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Andersson KE, Bende M. Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Laryngol 1984: 93: 179– 82. 2 Andersson M, Andersson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity. Relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988: 82: 1019– 26. 3 Andersson M, Andersson P, Pipkorn U. Allergen-induced specific and non-specific nasal hyperreactivity. Reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol (Stockh) 1989: 107: 207– 7. 4 Andersson M, Andersson P, Venge P, Pipkorn U. Eosinophils and eosinophil cationic protein (ECP) in nasal lavages during allergen-induced hyperresponsiveness. Effect of topical glucocorticosteroid treatment. Allergy 1989: 44: 342– 8. 5 Andersson M, Pipkorn U. The effect of platelet activating factor on nasal hypersensitivity. Eur J Clin Pharmacol 1988: 35: 231– 5. 6 Andersson M, Von Kogeren B, Andersson P, Pipkorn U. Allergen induced hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction. Allergy 1987: 42: 631– 7. 7 Baker C, Altman LC. The effect of dexamethasone and cromolyn sodium on intercellular adhesion molecules-1 expression on human nasal epithelial cells [abstract]. J Allergy Clin Immunol 1992: 89: 212. 8 Balle VH, Pedersen U, Engby B. Allergic perennial and nonallergic vasomotor rhinitis treated with budesonide nasal spray. Rhinology 1980: 18: 135– 42. 9 Baroody F, Eichtenstein EM, Kagey-Sobotka A, Proud D, Naclerio RM. Topical steroids inhibit antigen induced nasal hyperreactivity to histamine [abstract]. J Allergy Clin Immunol 1989: 82: 163. 10 Bascom R, Pipkorn U, Gleich G, Lichtenstein LM, Naclerio RM. Effect of systemic steroids on eosinophils and major basic protein during nasal antigen challenge [abstract]. J Allergy Clin Immunol 1986: 77: 246. 11 Bascom R, Pipkorn U, Eichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic corticosteroids. Am Rev Respir Dis 1988: 138: 406– 12. 12 Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli S, Eichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988: 81: 580– 9. 13 Batts AH, Marriott C, Martin GP, Bond SW. The effect of some preservatives used in nasal preparations on mucociliary clearance. J Pharm Pharmacol 1989: 41: 156– 9. 14 Baumgarten CR, Togias A, Naclerio RM, Norman PS, Eichtenstein LM, Proud D. Kininogens are generated following nasal challenge with allergen in allergic individuals but not in non-allergic individuals. J Clin Invest 1985: 76: 191– 7. 15 Bende M, Eindqvist N, Pipkorn U. The effect of a topical steroid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy 1983: 38: 461– 4. 16 Bentley AM, Cumberworth V, Varney VA, et al. Studies during the pollen season in understanding allergic rhinitis. In: P Godard, J Bousquet, FB Michel, eds. Advances in allergology and clinical immunology. Carnforth : Panthenon, 1992: 457– 64. 17 Beswick KB, Kenyon GS, Cherry JR. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in seasonal allergic rhinitis. Curr Med Res Opin 1985: 9: 560– 7. 18 Bisgaard H, Grønborg H, Mygind N, Dahl R, Venge P. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990: 85: 891– 5. 19 Borum P. Nasal methacholine challenge. A test for the measurement of nasal reactivity. J Allergy Clin Immunol 1979: 63: 63– 7. 20 Borum P, Geønborg H, Brofeldt S, Mygind N. Nasal reactivity in rhinitis. Eur J Respir Dis 1983: 64 (Suppl. 128): 65– 71. 21 Borum P, Grønborg H, Mygind N. Seasonal allergic rhinitis and depot injection of a corticosteroid. Allergy 1987: 42: 26– 32. 22 Bousquet J, Chanal I, Alqué MC, et al. Prevention of pollen rhinitis. Comparison of fluticasone propionate aqueous nasal spray versus disodium cromoglycate nasal spray. Allergy 1993 (in press). 23 Brogden RN, Heel RC, Speight TM, Avery GS. Beclomethasone dipropionate. A reappraisal of its pharmaco-dynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984: 28: 28– 126. 24 Brown HM, Storey G, Jackson FA. Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five year's experience. Br J Clin Pharmacol 1977: 4 (Suppl. 3): 283– 6. 25 Bunnag C, Jareoncharsri P, Wong ECK. A doubleblind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy 1992: 47: 313– 17. 26 Chaplin I, Haynes JT, Spahn I. Are nasal polyps an allergic phenomenon? Ann Allergy 1971: 29: 63– 4. 27 Clissold SP. Rhinitis. In: PJ Barnes, N Mygind, eds. Budesonide: clinical experience in asthma and rhinitis. Manchester : ADIS Press, 1988: 51– 64. 28 Cockcroft DW, Maccormack DW, Newhouse MT, Hargreave FE. Beclomethasone dipropionate in allergic rhinitis. Can Med Assoc J 1976: 115: 523– 6. 29 Connell JT. Quantitative intranasal pollen challenges: the priming effect in allergic rhinitis. J Allergy 1969: 43: 33– 44. 30 Cox G, Ohtoshi T, Vancheri C, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991: 4: 525– 31. 31 Cruz AA, Togias AG, Lichtenstein LM, Kageysobotka A, Proud D, Naclerio RM. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold dry air. Am Rev Respir Dis 1991: 143: 761– 5. 32 Czarny D, Brostoff J. Effect of intranasal beta-methasone-17-valerate on perennial rhinitis and adrenal function. Lancet 1968: 2: 188– 90. 33 Dahl R. Early and late phase reactions in the bronchi and the nose. In: N Mygind, U Pipkorn, R Dahl, eds. Rhinitis and asthma: similarities and differences. Copenhagen : Munksgaard, 1990: 203– 12. 34 Dahl R. The effect of fluticasone propionate aqueous nasal spray in seasonal rhinitis [abstract]. Allergy 1992: 47 (Supply. 12): 346. 35 Dahl R, Johansson S-Å. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis 1982: 63 (Suppl. 122): 167– 75. 36 Davies RJ, Lozewicz N, Manolitsas N, Calderon M, Devalia JL. Inflammatory cell recruitment following allergen exposure. In: P Godard, J Bousquet, FB Michel, eds. Advances in allergology and clinical immunology. Carnforth : Panthenon, 1992: 233– 44. 37 Delaney JC. Aspirin idiosyncrasy in patients admitted for nasal polypectomy. Clin Otolaryngol 1976: 1: 27– 30. 38 Deuschl H, Drettner B. Nasal polyps treated with beclomethasone nasal aerosol. Rhinology 1977: 15: 17– 23. 39 Dolovich J, Hargreave FE, Jordana M, Denburg J. Late-phase airway reaction and inflammation. J Allergy Clin Immunol 1989: 83: 521– 4. 40 Dolovich J, Ohtoshi T, Jordana M, Gauldie J, Denburg J. Nasal polyps: local inductive microenvironment in the pathogenesis of the inflammation. In: N Mygind, U Pipkorn, R Dahl, eds. Rhinitis and asthma. Similarities and diflferences. Copenhagen : Munksgaard, 1990: 233– 41. 41 Drake-Lee AB. Nasal polyps. In: N Mygind, RM Naclerio, eds. Allergic and non-allergic rhinitis. Clinical aspects. Copenhagen : Munksgaard, 1993: 167– 73. 42 Drettner B, Ebbbsen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982: 20: 149– 58. 43 Druce HM, Wright R, Kossof D, Kaliner M. Cholinergic nasal hyperreactivity in atopic patients. J Allergy Clin Immunol 1985: 76: 445– 52. 44 Durham SR, Hamid O, Sun Ying, et al. Cytokine mRNA expression for IL-3, IL-4, IL-5 and GM-CSF in the nasal mucosa after allergen provocation [abstract]. J Allergy Clin Immunol 1992: 89: 239. 45 Easton JG. Effect of an inhaled corticosteroid on methacholine airway reactivity. J Allergy Clin Immunol 1981: 67: 388– 90. 46 Enerbäck L, Pipkorn U, Graneus G. Intraepithelial migration of nasal mucosal mast cells in hay fever. Int Arch Allergy Appl Immunol 1986: 80: 44– 51. 47 Enerbäck L, Pipkorn U, Olsson A. Intraepithelial migration of nasal mucosal mast cells in hay fever: ultrastructural observations. Int Arch Allergy Appl Immunol 1986: 81: 289. 48 Farr BM, Gwaltney JM JR, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990: 162: 1173– 7. 49 Feather I, Wilson S, Smith S, Howarth P. Prophylactic fluticasone propionate aqueous nasal spray alters the symptoms of seasonal allergic rhinitis and suppresses mucosal mast cell and eosinophil number. Eur Respir J 1992 (in press). 50 Feiss G, Welch M, Meltzer E, Alderfer V, Smith J. The predictive value of nasal eosinophilia for therapetic response intranasal corticosteroid treatment in perennial allergic rhinitis [abstract]. J Allergy Clin Immunol 1992: 89: 209. 51 Findley S, Huber F, Garcia J, Huang L. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 1992: 68: 228– 32. 52 Fokkens WJ, Godthelp T, Holm AF, Mulder PGH, Vroom TM, Rijntjes E. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls. Clin Exp Allergy 1992: 22: 701– 10. 53 Fokkens WJ, Godthelp T, Holm AF, Mulder PGH, Vroom TM, Rijntjes E. The effect of nasal corticosteroid spray on Langerhans cells in the nasal mucosa. 1992 (in press). 54 Frauenfelder FT, Myer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 1990: 109: 489– 90. 55 Freeland H, Pipkorn U, Proud D, Naclerio RM, Lichtenstein LM, Peters SP. Leukotriene B4 as a mediator of early and late reactions to antigen in humans. The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol 1989: 83: 634– 42. 56 Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986: 77: 527– 37. 57 Frølund E. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol 1992: 16: 527– 31. 58 Fukuda T, Sato Y, Nakajima H, Akutsu I, Makino S. Detection of IE-5 mRNA in bronchial biopsies from asthma by nonradioactive in situ hybridization [abstract]. J Allergy Clin Immunol 1992: 89: 213. 59 Gomez E, Clague J, Gatland D, Davies R. Effect of topical corticosteroids on seasonally induced increase in nasal mast cells. BMJ 1988: 246: 1572– 3. 60 Grønborg H, Bisgaard H, Rømeling F, Lindqvist N, Mygind N. Nasal symptom response to allergen provocation: effect of the glucocorticoid budesonide. Allergy 1993: 48: 87– 93. 61 Grønborg H, Borum P, Mygind N. Histamine and methacholine do not increase nasal reactivity. Clin Allergy 1986: 16: 597– 602. 62 Hallworth GW, Padfield JM. A comparison of regional deposition in a model nose of a drug discharged from metered aerosol and metered-pump nasal delivery system. J Allergy Clin Immunol 1986: 77: 348– 53. 63 Hansen I, Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis. Acta Allerg (Kbh) 1974: 29: 281– 7. 64 Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990: 84 (Suppl. A): 25– 9. 65 Harding SM, Heath S. Intranasal steroid aerosol in perennial rhinitis: comparison with an antihistamine compound. Clin Allergy 1976: 6: 369– 72. 66 Hargreave FE. Late-phase asthmatic responses and air-way inflammation. J Allergy Clin Immunol 1989: 83: 525– 7. 67 Hargreave FE, Ryan G, Thomson NC, et al. Bronchial responsiveness to histamine and methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol 1981: 68: 347– 55. 68 Hastie R, Heroy JH, Levy DA. Basophil leukocytes and mast cells in human nasal secretions and scrapings studied by light microscopy. Lab Invest 1979: 49: 541– 6. 69 Haye R, Kolbenstedt A. Local atrophy at the site of injection of depot steroids. Tidsskr Nor Laegeforen 1984: 104: 1532– 3. 70 Henriksen J, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984: 130: 1014– 18. 71 Holopainen E, Grahne B, Malmberg H, Makinen J, Eindqvist N. Budesonide in the treatment of nasal poly-posis. Eur J Respir Dis 1982: 63 (Suppl. 122): 221– 8. 72 Horak F, Matthew H. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind crossover study. Ann Allergy 1982: 48: 305. 73 Howarth P, Wilson S, Lau E, Rajakulasingam K. The nasal mast cell and rhinitis. Clin Exp Allergy 1990: 21 (Suppl. 2): 3– 8. 74 Håkansson B, Linder C, Ohlsson K, Tegner H, Toremalm NG. Inhibitory effect of nasal drops components on granulocyte phagocytosis. Pharmacol Toxicol (in press). 75 Irani AA, Schechter NM, Craig SS, Debois G, Schwartz EB. TWO types of human mast cells that have distinctive neutral protease composition. Proc Natl Acad Sci USA 1986: 83: 4464– 8. 76 Jacobi H, Stahl-Skov P, Bindslev-Jensen C, Prætorius C, Weeke B, Mygind N. Histamine and tryptase in nasal lavage fluid following challenge with allergen and methacholine. Allergy (submitted) 1993. 77 Jacobson MR, Bentley AM, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increase in activated eosinophils and epithelial mast cells [abstract]. J Allergy Clin Immunol 1992: 89: 216. 78 Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous spray, astemizole, and the combination in the prophylactic treatment of ragweed-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989: 83: 627– 33. 79 Karlsson G, Rundcrantz H. A randomized trial of intranasal beelomethasone dipropionate after polypectomy. Rhinology 1982: 20: 144– 8. 80 Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991: 87: 893– 910. 81 Klementsson H, Andersson M. Eosinophil chemotactic activity of PAF on the human nasal mucosa. Eur J Clin Pharmacol 1992: 42: 295– 9. 82 Klementsson H, Andersson M, Baumgarten C, Venge P, Pipkorn U. Changes in non-specific reactivity and eosinophil influx and activation after allergen challenge; time related but independent phenomena Clin Exp Allergy 1990: 20: 20– 47. 83 Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U, Persson CG. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991: 21: 705– 10. 84 Knani N, Denburg JA, Evans S, Conway M, Jordana M, Dolovich J. Depletion of T lymphocytes in nasal polyps treated by topical steroid [abstract]. J Allergy Clin Immunol 1992: 89: 221. 85 Konno A, Togawa K, Fujiwara T. The mechanisms involved in onset of allergic manifestations in the nose. Eur J Respir Dis 1983: 64 (Suppl. 128): 155– 66. 86 Kwaselow A, Maclean J, Busse W, et al. A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. J Allergy Clin Immunol 1985: 40: 363– 7. 87 Laursen LC, Faurschou P, Munch E. Intramuscular betamethasone dipropionate vs topical beclomethasone dipropionate and placebo in hay fever. Allergy 1988: 43: 420– 3. 88 Laursen LC, Faurschou P, Pals H, Svendsen UG, Weeke B. Intramuscular betamethasone dipropionate vs oral prednisolone in hay fever patients. Allergy 1987: 42: 168– 72. 89 Eindqvist N, Andersson M, Bende M, Loeth S, Pipkorn U. The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 1989: 19: 71– 6. 90 Lindqvist N, Balle V, Karma P, et al. Long term safety and efficacy of budesonide nasal aerosol in perennial rhinitis - a 12 month multicenter study. Allergy 1986: 41: 179– 86. 91 Lindqvist N, Karlsson G, Pipkorn U. Adrenoceptor responsiveness of the allergic nasal mucosa. Effect of topical glucocorticoid treatment. ORL J Otorhinolaryngol Relat Spec (in press). 92 Löfkvist T, Svensson G. Treatment of vasomotor rhintis with beclomethasone dipropionate. Acta Allerg (Kbh) 1976: 31: 227– 38. 93 Lund V. Fluticasone propionate - a new and effective treatment for both allergic and non-allergic perennial rhinitis [abstract]. Allergy 1992: 12 (Suppl. 12): 347. 94 Lundgren JD, Shelhamer JH. Pathogenesis of airway mucus hypersecretion. J Allergy Clin Immunol 1990: 85: 399– 417. 95 Mabry RL. Visual loss after intranasal corticosteroid injection. Incidence, causes, and prevention. Arch Otolaryngol 1981: 107: 484– 6. 96 Malm L, Wihl J-Å. Intranasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allerg (Kbh) 1976: 31: 245. 97 Malm L, Wihl J-Å, Lamm CJ, Lindqvist N. Reduction of methacholine induced nasal secretions by the treatment with a new topical steroid in perennial non-allergic rhinitis. Allergy 1982: 36: 209– 14. 98 Mattoli S, Vittori E, Marini M. Corticosteroids down regulate the increased expression of GM-CSF IL6 and IL8 in bronchial epithelium of asthmatic patients [abstract]. J Allergy Clin Immunol 1992: 89: 164. 99 Mckenzie AW. Percutaneous absorption of steroids. Arch Dermatol 1962: 86: 611– 13. 100 Meltzer EO, Busse WW, Druce HM, et al. Assessment of flunisolide nasal spray versus placebo as an adjunct to antibiotic treatment of sinusitis [abstract]. J Allergy Clin Immunol 1992: 89: 301. 101 Meltzer EO, Orgel HA, Bronshy EA, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990: 86: 221– 30. 102 Montefort S, Feather IH, Wilson SJ, et al. The expression of leukocyte-endothelial adhesion molecules is increased in allergic rhinitis. Am J Respir Cell Mol Biol 1992: 7: 393– 8. 103 Munch E, Gomez G, Mygind N, et al. An open comparison of dosage frequency of beclomethasone dipropionate in seasonal allergic rhinitis. Chn Allergy 1981: 11: 303– 9. 104 Munch E, Søborg M, Nørreslet TT, Mygind N. A comparative study of dexchlopheniramine maleate sustained tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy 1983: 38: 517– 24. 105 Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. BMJ 1973: 4: 464– 6. 106 Mygind N. Nasal allergy. 2nd ed. Oxford : Blackwell Scientific, 1979. 107 Mygind N. Topical steroid treatment for allergic rhinitis and allied conditions. Clin Otolaryngol 1982: 7: 343– 52. 108 Mygind N, Pedersen CB, Prytz S, Sørensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975: 5: 159– 64. 109 Mygind N, Secher C, Kirkegaard J. Role of antihistamines in the nose. Eur J Respir Dis 1983: 64 (Suppl. 128): 16– 20. 110 Mygind N, Sørensen H, Pedersen CB. The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol. A light- and scanning-electron-microscopic study of nasal polyps. Acta Otolaryngol (Stockh) 1978: 85: 437– 43. 111 Mygind N, Versterhauge S. Aerosol distribution in the nose. Rhinology 1978: 16: 79– 88. 112 Naclerio RM. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol 1988: 82: 927– 34. 113 Naclerio RM. Inflammation in allergic rhinitis. Res Clin Forums 1992: 14: 49– 55. 114 Naclerio RM, Creticos R, Norman PS, Hamilton R. Intranasal steroids suppress the seasonal rise in antigen specific IgE [abstract]. J Allergy Clin Immunol 1991: 87: 221. 115 Naclbrio RM, Mygind N. Intranasal steroids. In: N Mygind, RM Naclerio, eds. Allergic and non-allergic rhinitis: clinical aspects. Copenhagen : Munksgaard, 1993: 114– 22. 116 Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N EngI J Med 1985: 313: 65– 70. 117 Nakajima H, Fukuda T, Ando N, Ohashi Y, Ezure M, Makino S. Increased numbers of CD4 + and CD25 + cells in the bronchial mucosa after antigen inhalation challenge in allergic asthma [abstract]. J Allergy Clin Immunol 1992: 89: 215. 118 Nathan RA, Bronsky EA, Fireman P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991: 67: 332– 8. 119 Newman SP, Moren F, Clarke SW. Deposition pattern from a nasal pump spray. Rhinology 1987: 25: 77– 82. 120 Norman PS, Winkenwerder WL, Agbayani BF, Migeon CJ. Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever. J Allergy Clin Immunol 1967: 40: 57– 61. 121 Okuda M, Kawabori S, Ohtsuka H. Basophil leukocytes and mast cells in the nose. Eur J Respir Dis 1983: 64 (Suppl. 128): 7– 14. 122 Okuda M, Othsuka H. Basophilic cells in allergic nasal secretions. Arch Otorhinolaryngol 1977: 214: 283– 9. 123 Okuda M, Othsuka H, Sakaguchi K, Ohnishi M, Okubo K. Effect of anti-allergic treatment on nasal surface basophilic metachromatic cells in allergic rhinitis. Allergy Proc 1989: 10: 23– 6. 124 Okuda M, Senba O. Effect of beclomethasone dipropionate nasal spray on subjective and objective findings in perennial rhinitis. Clin Otolaryngol 1980: 53: 15– 21. 125 Orgel HA, Meltzer EO, Bierman CW, et al. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol 1991: 88: 257– 64. 126 Orgel HA, Meltzer EO, Kemp JP, Welch MJ. Clinical, rhinomanometric, and cytological evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol. J Allergy Clin Immunol 1986: 77: 858– 64. 127 Otsuka H, Denburg JA, Befus AD, et al. Effect of beclomethasone dipropionate on nasal metachromatic cell subpopulation. Clin Allergy 1986: 16: 589– 95. 128 Pakes GE, Brogden RN, Heel RD, Speight TM, Avery GS. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis. Drugs 1980: 19: 397– 411. 129 Pedersen B, Larsen BB, Dahl R, Lindqvist N, Mygind N. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis. Allergy 1991: 46: 582– 7. 130 Pelikan Z. The effect of disodium cromoglycate and beclomethasone dipropionate on the late nasal mucosa response to allergen challenge. Ann Allergy 1982: 49: 200– 12. 131 Pepys J, Hutchroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1975: 112: 928– 59. 132 Persson CGA, Pipkorn U. Pathogenesis and pharmacology of asthma and rhinitis. In: N Mygind, U Pipkorn, R Dahl, eds. Rhinitis and asthma: similarities and differences. Copenhagen : Munksgaard, 1990: 275– 88. 133 Pichler WJ, Klint T, Blaser M, et al. Clinical comparison of systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis. Allergy 1988: 43: 87– 92. 134 Pipkorn U. Budesonide and nasal allergen challenge testing in man. Allergy 1982: 37: 129– 34. 135 Pipkorn U. Budesonide and nasal histamine challenge. Allergy 1982: 37: 359– 63. 136 Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 1983: 38: 125– 9. 137 Pipkorn U, Andersson P. Budesonide and nasal mucosal histamine content and anti-IgE induced histamine release. Allergy 1982: 37: 591– 5. 138 Pipkorn U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever: effect of topical glucocorticoid treatment. Int Arch Allergy Appl Immunol 1987: 84: 123– 8. 139 Pipkorn U, Karlsson G, Enerbäck L. Cellular response of the human allergic nasal mucosa to natural allergen exposure. J Allergy Clin Immunol 1988: 82: 1046– 54. 140 Pipkorn U, Karlsson G, Enerbäck L. Phenotypic expression of proteoglycan of mast cells of human nasal mucosa. Histochem J 1988: 20: 519– 25. 141 Pipkorn U, Norman PS, Middleton E Jr. Topical steroids. In: N Mygind, B Weeke, eds. Allergic and vasomotor rhinitis: clinical aspects. Copenhagen : Munksgaard, 1985: 165– 79. 142 Pipkorn U, Proud D, Lichtenstein LM, Kageysobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987: 316: 1506– 10. 143 Pipkorn U, Proud D, Schleimer RP, et al. Effects of short term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987: 80: 957– 61. 144 Pipkorn U, Pukander J, Suonpaa J, Makinen J, Lindqvist N. Long-term safety of budesonide nasal aerosol - a 5 1/2 year follow up study. Clin Allergy 1988: 18: 253– 9. 145 Pipkorn U, Rundcrantz H, Lindqvist N. Budesonide - a new nasal steroid. Rhinology 1980: 18: 171– 5. 146 Proud D, Togias A, Naclerio RM, Crush S, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983: 72: 1678– 85. 147 Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma. J Allergy Ciin Immunol 1988: 81: 1042– 7. 148 Ryan G, Latimer KM, Juniper EF, Roberts RS, Hargreave FE. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. J Allergy Clin Immunol 1985: 75: 25– 30. 149 Sahay JN, Chatterjee SS, Engler C. A comparative trial of flunisolide and beclomelhasone dipropionate in the treatment of perennial allergic rhinitis. Clin Allergy 1980: 10: 65– 70. 150 Salomonsson P, Gottberg L, Heilborn H, Norrlind K, Pegelow KO. Efficacy of an oral antihistamine, astemizole, as compared to a nasal steroid spray in hay fever. Allergy 1988: 43: 214– 18. 151 Sarnstrand B, Jeppsson Å, Malmstrom A, Brattsand R. Effect of glucocorticosteroids on hyaluronic acid synthesis in vitro in human fibroblast-like cells from lung and skin. In: JC Hogg, R Ellul-Micalef, R Brattsand, eds. Glucocorticosteroids, inflammation and bronchial hyperreactivity. Amsterdam : Excerpta Medica, 1985: 157– 66. 152 Scadding GK, Lund VJ, Holmstrand M, Darby YC. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991: Suppl. 11: 37– 43. 153 Secher C, Kirkegaard J, Borum P, Maansson A, Osterhammel P, Mygind N. Significance of H1, and H2 receptors in the human nose. J Allergy Clin Immunol 1982: 70: 211– 18. 154 Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988: 81: 984– 91. 155 Siegel SC, Katz R, Rachelefsky GS, et al. Multicenter study of beclomethasone dipropionate in adults with seasonal allergic rhinitis. J Allergy Clin Immunol 1982: 69: 345– 53. 156 Sim TC, Alam R, Hilsmeier KA, Grant JA. Detection of inflammatory cytokines in nasal secretions of allergic subjects following antigen challenge [abstract]. J Allergy Clin Immunol 1992: 89: 287. 157 Sim TC, Hilsmeier KA, Alam R, Allen RK, Lett-Brown MA, Grant JA. Effect of topical corticosteroids on the recovery of histamine releasing factors in nasal washings of patients with allergic rhinitis. Am Rev Respir Dis 1992: 145: 1316– 20. 158 Small P, Black M, Frenkiel S. Effect of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982: 70: 78– 82. 159 Soderberg-Warner ML. Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 1984: 105: 840– 1. 160 Sousa AR, Lane SJ, Nakhosteen J, Lee TH, Poston RN. Increased GM-CSF expression in the bronchial epithelium of asthmatic patients demonstrated by immunohistochemistry [abstract]. J Allergy Clin Immunol 1992: 89: 164. 161 Stafanger G. In vitro effect of beclomethasone dipropionate and flunisolide on mobility of human nasal cilia. Allergy 1987: 42: 507– 11. 162 Storms W, Bronsky E, Findley S, et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy 1991: 66: 329– 34. 163 Svensjö E, Roempke K. Time-dependent inhibition of bradykinin and histamine-induced increase in microvascular permeability by local glucocorticosteroid treatment. In: JC Hogg, R Ellul-Michalef, R Brattsand, eds. Glucocorticosteroids, inflammation and bronchial hyperreactivity. Amsterdam : Excerpta Medica, 1985: 136– 44. 164 Svensson C, Greiff L, Andersson M, Alkner U, Persson CG. Topical steroids may not inhibit vascular permeability in human airways [abstract]. Clin Exp Allergy 1992 (in press). 165 Svensson C, Klementsson H, Persson CGA, Pipkorn U. A topical glucocorticoid reduced levels of fibrinogen and bradykinins on the allergic nasal mucosa during natural pollen exposure. 1990 (submitted). 166 Svensson C, Pipkorn U, Baumgarten CR, Alkner U, Persson CGA. Reversibility and reproducibility of histamine-induced plasma leakage of the human nasal airways. Thorax 1989: 44: 13– 18. 167 Sørensen H, Mygind N, Pedersen CB, Prytz S. Long term treatment of nasal polyps with beclomethasone dipropionate aerosol. III. Acta Otolaryngol (Stockh) 1976: 82: 82– 2. 168 Tarlo SM, Cockcroft DW, Dolovich J, Hargreave FE. Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977: 59: 232– 6. 169 Thomas KE, Ollier S, Ferguson H, Davies RJ. The effect of intranasal azelastine on nasal airways obstruction and sneezing following provocation testing with histamine and allergen. Clin Exp Allergy 1992: 22: 642– 7. 170 Thorsson L, Newman SP, Weisz A, Trofast E, Móren F. Nasal distribution of budesonide inhaled via a powder inhaler. Rhinology 1993: 31: 7– 10. 171 Toft A, Wihl J-Å, Toxman J, Mygind N. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy 1982: 12: 391– 401. 172 Togias AG, Naclerio RM, Proud D, et al. Nasal challenge with cold, dry air results in release of inflammatory mediators: possible mast cell involvement. J Clin Invest 1985: 76: 1375– 81. 173 Togias AG, Proud D, Lichtenstein LM, et al. The osmolarity of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis 1988: 137: 625– 9. 174 Trevor T, Hansel MD, de Vries IJ, et al. Eosinophils from the respiratory tissue of asthmatics express functional ICAM-1 and HLA-DR [abstract]. J Allergy Clin Immunol 1992: 89: 165. 175 Turkeltaub PC, Norman PS, Crepea S. Treatment of ragweed hay fever with an intranasal spray containing flunisolide: a new synthetic corticosteroid. J Allergy Clin Immunol 1976: 58: 597– 606. 176 Van As A, Bronsky E, Grossman J, Meltzer EO, Ratner P, Reed C. Dose tolerance study of flutocasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991: 67: 156– 62. 177 van Wijk RG. Nasal hyperresponsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin Allergy 1987: 17: 563– 70. 178 Vanzieleghem MA, Juniper EF. A comparison of budesonide and beclomethasone dipropionate nasal aerosols in ragweed-induced rhinitis. J Allergy Clin Immunol 1987: 79: 887– 92. 179 Venge P, Håkansson L, Rak S, Dahl R, Fredens K. Inflammatory cells in asthma and rhinitis. In: N Mygind, U Pipkorn, R Dahl, eds. Rhinitis and asthma: similarities and differences. Copenhagen : Munksgaard, 1990: 188– 202. 180 Viegas M, Gomez E, Brooks J, Gatland D, Davies RJ. Effect of the pollen season on nasal mast cells. BMJ 1987: 294: 414. 181 Vilsviik JS, Jenssen AO, Walstad R. The effect of beclomethasone dipropionate aerosol on allergen induced nasal stenosis. Chn Allergy 1975: 5: 291– 4. 182 Wagenmann M, Baroody FM, Naclerio RM, et al. Effect of H1-antagonism on nasal reflexes after unilateral allergen challenge [abstract]. J Allergy Clin Immunol 1992: 89: 205. 183 Wardlaw AJ, Bentlby AM, Menz G, Storz C, Durham SR, Kay AB. Expression of the adhesion molecules ICAM-1 and ELAM-1 in the bronchial mucosa in asthma [abstract]. J Allergy Clin Immunol 1992: 89: 164. 184 Welch MJ, Bronsky EA, Grossman J, et al. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy 1991: 67: 493– 8. 185 Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987: 62: 125– 34. 186 Whelan CFA. Problems in the examination of nasal smears in allergic rhinitis. J Laryngol Otol 1980: 84: 399– 405. 187 Wight RG, Jones AS, Beckingham E, Andersson B, Ek L. A double-blind comparison of intranasal budesonide 400 μg and 800 μg in perennial rhinitis. Clin Otolaryngol 1992: 17: 354– 8. 188 Wihl J-Å, Brofeldt S, Grønborg H, Borum P, Mygind N. Blind study of basophilic cells in nasal smears from patients with grass pollen hay fever. Eur J Respir Dis 1983: 64 (Suppl. 128): 383– 6. 189 Wihl J-Å, Petersen BN, Petersen LN, Gundersen G, Bresson K, Mygind N. Effect of the non-sedating H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 1985: 75: 720– 5. 190 Winther B, Innes DJ, Mills SE, Mygind N, Zito D, Hayden FG. Lymphocyte subsets in the normal airway mucosa of the human nose. Arch Otolaryngol 1987: 113: 59– 62. 191 Wolthers OD, Pedersen S. Short term linear growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids. Acta Paediatr Scand 1993 (in press). 192 Wood SFG. Oral antihistamine and nasal steroid in hay fever. Clin Allergy 1986: 16: 195– 201. Citing Literature Volume48, Issue7October 1993Pages 476-490 ReferencesRelatedInformation